This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Farmarc Nederland Bv. Active years: 1997-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Cape Town, ZA (1997)
- Newlands, ZA (2000)
Company Filing History:
Years Active: 1997-2000
Title: Mino Rodolfo Caira: Innovator in Pharmaceutical Chemistry
Introduction
Mino Rodolfo Caira is a notable inventor based in Newlands, South Africa. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the area of drug formulation. With a total of 2 patents to his name, Caira's work focuses on innovative processes that enhance the efficacy of pharmaceutical compounds.
Latest Patents
Caira's latest patents include a process for the optical resolution of 3-(p-chlorophenyl)-glutaramide and an inclusion complex of beta-cyclodextrin and diclofenac. The latter patent describes a formulation that combines one molecule of diclofenac, preferably as diclofenac sodium, with one molecule of unsubstituted beta-cyclodextrin, along with 5 to 11 water molecules. This inclusion complex can be formulated as a pharmaceutical composition, showcasing Caira's expertise in drug delivery systems.
Career Highlights
Caira is currently associated with Farmarc Nederland Bv, where he continues to develop innovative pharmaceutical solutions. His work has been instrumental in advancing the understanding of drug interactions and formulations, contributing to improved therapeutic outcomes.
Collaborations
Caira has collaborated with notable colleagues, including Mark David Bodley and Lueta Ann Glintenkamp. These partnerships have fostered a collaborative environment that enhances research and development efforts in the pharmaceutical sector.
Conclusion
Mino Rodolfo Caira's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the field. His work continues to influence drug formulation and delivery, making a significant impact on healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile